Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate-to-severe Atopic Eczema”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03334396
What this trial is testing

Baricitinib (LY3009104) in Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Eli Lilly and Company 660
Testing effectiveness (Phase 2)Study completedNCT02347176
What this trial is testing

Phase 2 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
MedImmune LLC 204
Large-scale testing (Phase 3)Looking for participantsNCT06723080
What this trial is testing

Phase III Clinical Study of VC005 Tablets in Adult Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Moderate to Severe Atopic Dermatitis
Jiangsu vcare pharmaceutical technology co., LTD 480
Not applicableNot Yet RecruitingNCT04730024
What this trial is testing

Long-term Follow-up Study to Evaluate the Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD Inj

Who this might be right for
Atopic Dermatitis
Kang Stem Biotech Co., Ltd. 102
Not applicableStudy completedNCT07577921
What this trial is testing

Evaluation of the Efficacy of a Cosmetic Care in Subjects With Moderate to Severe Atopic Dermatitis, Treated by Systemic Treatments

Who this might be right for
Atopic Dermatitis
Pierre Fabre Dermo Cosmetique 80
Large-scale testing (Phase 3)UnknownNCT06383468
What this trial is testing

A Phase III Study to Evaluate the Efficacy and Safety of AK120 in Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Akeso 420
Testing effectiveness (Phase 2)Study completedNCT06085521
What this trial is testing

LNK01001 Capsule in Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Lynk Pharmaceuticals Co., Ltd 150
Large-scale testing (Phase 3)Active Not RecruitingNCT06552520
What this trial is testing

To Evaluate the Phase III Clinical Trial of TQH2722 Injection in the Treatment of Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. 500
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06158490
What this trial is testing

Evaluate JYP0061 Tablets in Patients With Moderate-to-severe Atopic Dermatitis

Who this might be right for
Moderate-to-severe Atopic Dermatitis
Guangzhou JOYO Pharma Co., Ltd 120
Testing effectiveness (Phase 2)Ended earlyNCT03517566
What this trial is testing

Assess the Safety and Efficacy of ZPL389 in Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Novartis Pharmaceuticals 293
Early research (Phase 1)Study completedNCT03556592
What this trial is testing

Drug-drug Interaction Trial With Tralokinumab in Moderate to Severe Atopic Dermatitis - ECZTRA 4

Who this might be right for
Atopic Dermatitis
LEO Pharma 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07175233
What this trial is testing

Evaluate the Efficacy, Safety of SIM0278 in Subjects With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
Jiangsu Simcere Pharmaceutical Co., Ltd. 184
Not applicableLooking for participantsNCT05819463
What this trial is testing

Treatment and Medical Care of Patients With Moderate-to-severe Atopic Dermatitis - TREATswitzerland

Who this might be right for
Atopic Dermatitis
Swiss Society of Dermatology and Venereology 700
Testing effectiveness (Phase 2)Study completedNCT04444752
What this trial is testing

Assess the Efficacy and Safety of CBP-201 in Adult Subjects With Moderate to Severe Atopic Dermatitis

Who this might be right for
Moderate-to-severe Atopic Dermatitis
Connect Biopharm LLC 226
Testing effectiveness (Phase 2)Looking for participantsNCT07193589
What this trial is testing

A Phase II Clinical Study Evaluating of ZL-82 Tablets in Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Chengdu Zenitar Biomedical Technology Co., Ltd 111
Early research (Phase 1)Study completedNCT06553209
What this trial is testing

Study of CM512 in Healthy Subjects and Patients With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Keymed Biosciences Co.Ltd 110
Testing effectiveness (Phase 2)Looking for participantsNCT07599813
What this trial is testing

A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic DermatitisAtopicDermatitis+5 more
Apollo Therapeutics Ltd 280
Testing effectiveness (Phase 2)Study completedNCT07103174
What this trial is testing

MG-K10 Humanized Monoclonal Antibody Injection in Subjects With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
Shanghai Mabgeek Biotech.Co.Ltd 60
Post-approval studies (Phase 4)Study completedNCT00925730
What this trial is testing

Open-label Study to Investigate Systemic Exposure in Adult and Pediatric Atopic Dermatitis Patients Treated 8.5 Days With Pimecrolimus Cream 1% Under Occlusion

Who this might be right for
Atopic Dermatitis
Novartis 20
Testing effectiveness (Phase 2)Study completedNCT01785602
What this trial is testing

Efficacy and Safety Study of QAW039 in the Treatment of Patients With Moderate to Severe Atopic Dermatitis.

Who this might be right for
Atopic Dermatitis
Novartis Pharmaceuticals 103
Next Page